DOMESTIC MYOCARDIAL CYTOPROTECTOR EFFECTIVENESS AND ITS PHARMACODYNAMICS IN ACUTE MYOCARDIAL ISCHEMIA: CLINICAL RESULTS AND EXPERIMENTAL MODELS

Anti-ischemic effects of high-dose cardiac cytoprotector Mexicor (0,014 g/kg/d, 0,019 g/kg/d) were examined in rabbits with experimental myocardial infarction. In addition, anti-ischemic activity of Mexicor (0,4 g/d) was assessed in patients with acute coronary syndrome (ACS). It has been demonstrat...

Full description

Saved in:
Bibliographic Details
Main Authors: V. P. Mikhin, M. V. Pokrovskyi, V. V. Gureev, O. A. Chernova, Yu. V. Alimenko, E. N. Bogoslovskaya
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2011-04-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/1101
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849410247300481024
author V. P. Mikhin
M. V. Pokrovskyi
V. V. Gureev
O. A. Chernova
Yu. V. Alimenko
E. N. Bogoslovskaya
author_facet V. P. Mikhin
M. V. Pokrovskyi
V. V. Gureev
O. A. Chernova
Yu. V. Alimenko
E. N. Bogoslovskaya
author_sort V. P. Mikhin
collection DOAJ
description Anti-ischemic effects of high-dose cardiac cytoprotector Mexicor (0,014 g/kg/d, 0,019 g/kg/d) were examined in rabbits with experimental myocardial infarction. In addition, anti-ischemic activity of Mexicor (0,4 g/d) was assessed in patients with acute coronary syndrome (ACS). It has been demonstrated that Mexicor reduced the size of infarction area and decreased the ratio “necrosis area / ischemia area”, compared to the control animals. In ACS patients, Mexicor facilitated faster recovery of left ventricular diastolic function, and also decreased blood levels of NT-proBNP.
format Article
id doaj-art-bfeecff74ef749d593fc0d3c99c09d35
institution Kabale University
issn 1560-4071
2618-7620
language Russian
publishDate 2011-04-01
publisher «FIRMA «SILICEA» LLC
record_format Article
series Российский кардиологический журнал
spelling doaj-art-bfeecff74ef749d593fc0d3c99c09d352025-08-20T03:35:11Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202011-04-01023742907DOMESTIC MYOCARDIAL CYTOPROTECTOR EFFECTIVENESS AND ITS PHARMACODYNAMICS IN ACUTE MYOCARDIAL ISCHEMIA: CLINICAL RESULTS AND EXPERIMENTAL MODELSV. P. Mikhin0M. V. Pokrovskyi1V. V. Gureev2O. A. Chernova3Yu. V. Alimenko4E. N. Bogoslovskaya5Курский государственный медицинский университет Росздрава, КурскКурский государственный медицинский университет Росздрава, КурскКурский государственный медицинский университет Росздрава, КурскКурский государственный медицинский университет Росздрава, КурскКурский государственный медицинский университет Росздрава, КурскКурский государственный медицинский университет Росздрава, КурскAnti-ischemic effects of high-dose cardiac cytoprotector Mexicor (0,014 g/kg/d, 0,019 g/kg/d) were examined in rabbits with experimental myocardial infarction. In addition, anti-ischemic activity of Mexicor (0,4 g/d) was assessed in patients with acute coronary syndrome (ACS). It has been demonstrated that Mexicor reduced the size of infarction area and decreased the ratio “necrosis area / ischemia area”, compared to the control animals. In ACS patients, Mexicor facilitated faster recovery of left ventricular diastolic function, and also decreased blood levels of NT-proBNP.https://russjcardiol.elpub.ru/jour/article/view/1101myocardial infarctionacute coronary syndromemexicorclinical settingsexperiment
spellingShingle V. P. Mikhin
M. V. Pokrovskyi
V. V. Gureev
O. A. Chernova
Yu. V. Alimenko
E. N. Bogoslovskaya
DOMESTIC MYOCARDIAL CYTOPROTECTOR EFFECTIVENESS AND ITS PHARMACODYNAMICS IN ACUTE MYOCARDIAL ISCHEMIA: CLINICAL RESULTS AND EXPERIMENTAL MODELS
Российский кардиологический журнал
myocardial infarction
acute coronary syndrome
mexicor
clinical settings
experiment
title DOMESTIC MYOCARDIAL CYTOPROTECTOR EFFECTIVENESS AND ITS PHARMACODYNAMICS IN ACUTE MYOCARDIAL ISCHEMIA: CLINICAL RESULTS AND EXPERIMENTAL MODELS
title_full DOMESTIC MYOCARDIAL CYTOPROTECTOR EFFECTIVENESS AND ITS PHARMACODYNAMICS IN ACUTE MYOCARDIAL ISCHEMIA: CLINICAL RESULTS AND EXPERIMENTAL MODELS
title_fullStr DOMESTIC MYOCARDIAL CYTOPROTECTOR EFFECTIVENESS AND ITS PHARMACODYNAMICS IN ACUTE MYOCARDIAL ISCHEMIA: CLINICAL RESULTS AND EXPERIMENTAL MODELS
title_full_unstemmed DOMESTIC MYOCARDIAL CYTOPROTECTOR EFFECTIVENESS AND ITS PHARMACODYNAMICS IN ACUTE MYOCARDIAL ISCHEMIA: CLINICAL RESULTS AND EXPERIMENTAL MODELS
title_short DOMESTIC MYOCARDIAL CYTOPROTECTOR EFFECTIVENESS AND ITS PHARMACODYNAMICS IN ACUTE MYOCARDIAL ISCHEMIA: CLINICAL RESULTS AND EXPERIMENTAL MODELS
title_sort domestic myocardial cytoprotector effectiveness and its pharmacodynamics in acute myocardial ischemia clinical results and experimental models
topic myocardial infarction
acute coronary syndrome
mexicor
clinical settings
experiment
url https://russjcardiol.elpub.ru/jour/article/view/1101
work_keys_str_mv AT vpmikhin domesticmyocardialcytoprotectoreffectivenessanditspharmacodynamicsinacutemyocardialischemiaclinicalresultsandexperimentalmodels
AT mvpokrovskyi domesticmyocardialcytoprotectoreffectivenessanditspharmacodynamicsinacutemyocardialischemiaclinicalresultsandexperimentalmodels
AT vvgureev domesticmyocardialcytoprotectoreffectivenessanditspharmacodynamicsinacutemyocardialischemiaclinicalresultsandexperimentalmodels
AT oachernova domesticmyocardialcytoprotectoreffectivenessanditspharmacodynamicsinacutemyocardialischemiaclinicalresultsandexperimentalmodels
AT yuvalimenko domesticmyocardialcytoprotectoreffectivenessanditspharmacodynamicsinacutemyocardialischemiaclinicalresultsandexperimentalmodels
AT enbogoslovskaya domesticmyocardialcytoprotectoreffectivenessanditspharmacodynamicsinacutemyocardialischemiaclinicalresultsandexperimentalmodels